104 related articles for article (PubMed ID: 11013611)
1. [MRI-guided percutaneous radiofrequency ablation of hepatic neoplasms--first technical and clinical experiences].
Huppert PE; Trübenbach J; Schick F; Pereira P; König C; Claussen CD
Rofo; 2000 Aug; 172(8):692-700. PubMed ID: 11013611
[TBL] [Abstract][Full Text] [Related]
2. [Percutaneous radiofrequency ablation of hepatic neoplasms using a "cluster" electrode--first clinical results].
Trübenbach J; König CW; Duda SH; Schick F; Huppert PE; Claussen CD; Pereira PL
Rofo; 2000 Nov; 172(11):905-10. PubMed ID: 11142123
[TBL] [Abstract][Full Text] [Related]
3. Use of semiflexible applicators for radiofrequency ablation of liver tumors.
Gaffke G; Gebauer B; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C
Cardiovasc Intervent Radiol; 2006; 29(2):270-5. PubMed ID: 16328685
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of radiofrequency ablation therapy in patients with hepatic cavernous hemangiomas].
Fan RF; Chai FL; He GX; Li RZ; Wan WX; Bai MD; Zhu WK; Cao ML; Li HM; Yan SZ
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(23):1608-12. PubMed ID: 16185527
[TBL] [Abstract][Full Text] [Related]
5. MR-guided radiofrequency ablation of hepatic malignancies at 1.5 T: initial results.
Mahnken AH; Buecker A; Spuentrup E; Krombach GA; Henzler D; Günther RW; Tacke J
J Magn Reson Imaging; 2004 Mar; 19(3):342-8. PubMed ID: 14994303
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
[TBL] [Abstract][Full Text] [Related]
7. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results].
Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL
Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547
[TBL] [Abstract][Full Text] [Related]
8. MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors.
Clasen S; Boss A; Schmidt D; Schraml C; Fritz J; Schick F; Claussen CD; Pereira PL
J Magn Reson Imaging; 2007 Oct; 26(4):1043-52. PubMed ID: 17896364
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous radiofrequency ablation with a multiple-electrode switching-generator system.
Weisbrod AJ; Atwell TD; Callstrom MR; Farrell MA; Mandrekar JN; Charboneau JW
J Vasc Interv Radiol; 2007 Dec; 18(12):1528-32. PubMed ID: 18057287
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients.
Gunabushanam G; Sharma S; Thulkar S; Srivastava DN; Rath GK; Julka PK; Bhatnagar S
J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):67-72. PubMed ID: 17296706
[TBL] [Abstract][Full Text] [Related]
14. [Radiofrequency ablation therapy combined with suture and ligation surgery for patients with giant cavernous hemangiomas of the liver].
Fan RF; Chai FL; He GX; Wan WX; Bai MD; Cao ML; Li HM; Yan SZ
Zhonghua Yi Xue Za Zhi; 2006 Aug; 86(30):2134-7. PubMed ID: 17064621
[TBL] [Abstract][Full Text] [Related]
15. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
[TBL] [Abstract][Full Text] [Related]
17. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.
Choy PY; Koea J; McCall J; Holden A; Osbourne M
N Z Med J; 2002 Aug; 115(1159):U128. PubMed ID: 12362172
[TBL] [Abstract][Full Text] [Related]
18. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
[TBL] [Abstract][Full Text] [Related]
19. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation.
Svatek RS; Sims R; Anderson JK; Abdel-Aziz K; Cadeddu JA
Urology; 2006 Mar; 67(3):508-12. PubMed ID: 16504265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
